CIK 0001557746
- Non-accelerated filer
- Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460571712
- Phone
- +1 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-03 | Loerop James Chief Business Officer | Exercise or conversion | +20,875 | 198,197 | ||
| 2026-02-03 | Loerop James Chief Business Officer | Shares withheld for taxes | −5,937 | $3.47 | $21K | 192,260 |
| 2026-02-03 | Loerop James Chief Business Officer | Exercise or conversion · Restricted Stock Units | −20,875 | 62,625 | ||
| 2026-02-02 | Loerop James Chief Business Officer | Grant or award · Restricted Stock Units | +97,700 | 97,700 | ||
| 2026-02-02 | Loerop James Chief Business Officer | Grant or award · Employee Stock Option (Right to Buy) | +341,900 | 341,900 | ||
| 2026-02-01 | Loerop James Chief Business Officer | Exercise or conversion | +11,250 | 165,758 | ||
| 2026-02-01 | Loerop James Chief Business Officer | Exercise or conversion | +7,500 | 173,258 | ||
| 2026-02-01 | Loerop James Chief Business Officer | Exercise or conversion | +14,750 | 188,008 | ||
| 2026-02-01 | Loerop James Chief Business Officer | Shares withheld for taxes | −10,686 | $3.51 | $38K | 177,322 |
| 2026-02-01 | Loerop James Chief Business Officer | Exercise or conversion · Restricted Stock Units | −11,250 | 0 | ||
| 2026-02-01 | Loerop James Chief Business Officer | Exercise or conversion · Resticted Stock Units | −7,500 | 7,500 | ||
| 2026-02-01 | Loerop James Chief Business Officer | Exercise or conversion · Restricted Stock Units | −14,750 | 29,500 | ||
| 2026-01-02 | Loerop James Chief Business Officer | Exercise or conversion | +18,150 | 161,212 | ||
| 2026-01-02 | Loerop James Chief Business Officer | Shares withheld for taxes | −6,171 | $2.88 | $18K | 155,041 |
| 2026-01-02 | Loerop James Chief Business Officer | Exercise or conversion · Restricted Stock Units | −18,150 | 18,700 | ||
| 2025-12-31 | Loerop James Chief Business Officer | Exercise or conversion | +73,750 | 177,056 | ||
| 2025-12-31 | Loerop James Chief Business Officer | Shares withheld for taxes | −33,994 | $3.01 | $102K | 143,062 |
| 2025-12-31 | Loerop James Chief Business Officer | Exercise or conversion · Restricted Stock Units | −73,750 | 0 | ||
| 2025-02-03 | Loerop James Chief Business Officer | Grant or award · Restricted Stock Units | +83,500 | 83,500 | ||
| 2025-02-03 | Loerop James Chief Business Officer | Grant or award · Employee Stock Option (Right to Buy) | +292,300 | 292,300 |
Page 1 of 3 · 53 trades